Communal Coping Intervention for Type 1 Diabetes
Trial Summary
What is the purpose of this trial?
This trial tests a program that helps couples work together to manage type 1 diabetes. It targets couples where one partner has diabetes, aiming to improve their teamwork in handling the disease. The program includes setting shared goals and receiving regular support messages.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on a coping intervention rather than medication changes.
What data supports the effectiveness of the treatment Communal Coping Intervention for Type 1 Diabetes?
Is the Communal Coping Intervention generally safe for humans?
How does the communal coping treatment for Type 1 Diabetes differ from other treatments?
The communal coping treatment for Type 1 Diabetes is unique because it focuses on shared illness appraisal and collaborative strategies between individuals and their partners, rather than solely on medical or individual approaches. This interpersonal method aims to improve health outcomes by enhancing relationship quality and reducing psychological distress through joint problem-solving and support.12367
Research Team
Vicki Helgeson, Ph.D.
Principal Investigator
Carnegie Mellon University
Eligibility Criteria
This trial is for adults over 18 with Type 1 Diabetes who've had it for at least a year. They must be married or living with a partner for the same duration, who's also willing to join the study. Participants need internet access and can't have other major illnesses overshadowing their diabetes. Non-English speakers and partners with diabetes are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Couples complete a baseline questionnaire assessment and have a videotaped conversation about coping with diabetes
Intervention
Participants receive either the communal coping intervention or diabetes education control, followed by 7 days of daily diaries and text message prompts for the intervention group
Follow-up
An in-person follow-up interview takes place 6 weeks after the initial session to assess outcomes and repeat the videotaped conversation
Treatment Details
Interventions
- Communal Coping Intervention (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Carnegie Mellon University
Lead Sponsor
Farnam Jahanian
Carnegie Mellon University
Chief Executive Officer since 2018
PhD in Computer Science from the University of Texas at Austin
Dr. Patrizia Cavazzoni
Carnegie Mellon University
Chief Medical Officer
MD from Harvard Medical School
Juvenile Diabetes Research Foundation
Collaborator
Dr. Aaron J. Kowalski
Juvenile Diabetes Research Foundation
Chief Executive Officer since 2019
PhD in Microbiology and Molecular Genetics from Rutgers University
Dr. Thomas Danne
Juvenile Diabetes Research Foundation
Chief Medical Officer
MD from Albert Einstein College of Medicine